EYE » Topics » Cataract/Implant sales rose 9.6% to $152.3 million in the quarter and 6.4% to $552.0 million for 2007.
This excerpt taken from the EYE 8-K filed Feb 14, 2008.
Cataract/Implant sales rose 9.6% to $152.3 million in the quarter and 6.4% to $552.0 million for 2007.
Intraocular lens (IOL) sales rose 7.6% to $85.7 million in the quarter and 8.8% to $317.2 million for 2007, reflecting
continuing demand for the companys Tecnis® monofocal IOLs and its portfolio of refractive IOLs.
Viscoelastics sales rose 9.7% to $33.6 million in the quarter and 0.3% to $123.4 million for 2007. Growth was driven
primarily by increased sales of the Healon® family of viscoleastics.
Phacoemulsification sales rose 10.7% to $26.4 million in the quarter and 3.6% to $90.7 million for 2007. The rise
reflected the mid-year launch of the WhiteStar SignatureTM system and increased surgeon usage of the companys existing phacoemulsification installed
base. Surgical pack sales rose 12.9% in the quarter and 9.5% for 2007.
Bet you've never seen portfolio analytics like these.